Exhibition Guide - EAU Annual Congress
Exhibition Guide - EAU Annual Congress
Exhibition Guide - EAU Annual Congress
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Company and Product Description<br />
OCEANA THERAPEUTICS<br />
Suite 602, Q House, 76 Furze Road, Sandyford, 18, Dublin,<br />
Ireland<br />
T : +353 1 293 01 53<br />
F : +353 1 293 01 66<br />
W : www.oceanatherapeutics.com<br />
E : Karen.Browne@oceanathera.com<br />
Level/Booth nr. : 2M03<br />
Oceana Therapeutics Ltd is a specialty company with<br />
a core technology of injectable co-polymer gels which<br />
provide durable tissue enhancement. Deflux is a safe<br />
and effective treatment option for VUR and male and<br />
female stress urinary incontinence.<br />
OLyMPUS MEDICAL SySTEMS<br />
EUROPA GMBH<br />
Wendenstrasse 14-18, 20097, Hamburg, Germany<br />
T : +49 402 377 357 46<br />
F : +49 402 377 357 31<br />
W : www.olympus-europa.com<br />
E : stefanie.thiele@olympus-europa.com<br />
Level/Booth nr. : 2M100<br />
The doctor’s mission is to provide high quality care<br />
for patients. Olympus contributes to this mission by<br />
developing new technology, maintaining high quality<br />
levels through optimal production systems, and by<br />
creating the optimal endoscopy environment.<br />
OM PHARMA SA<br />
22, Rue Du Bois-du-lan, 1217, Meyrin, Switzerland<br />
T : +41 227 831 288<br />
F : +41 227 831 122<br />
W : www.viforpharma.com<br />
E : regina.khediri@viforpharma.com<br />
Level/Booth nr. : 1P35<br />
OM Pharma, a company of the Vifor Pharma Group<br />
headquartered in Switzerland, is a world leader in<br />
immunoactive therapies. One of its leading brands,<br />
Uro-Vaxom ® , is indicated in the prevention of recurrent<br />
cystitis. Vifor Pharma is the pharma business sector of<br />
the Galenica Group.<br />
ORION PHARMA<br />
P.O. Box 65, 02101, Espoo, Finland<br />
T : +358 10 426 1<br />
F : +358 10 426 3815<br />
W : http://www.orion.fi/en/<br />
E : hanna.leena.seppanen@<br />
orionpharma.com<br />
Level/Booth nr. : 1P125<br />
Orion is an innovative European R&D-based<br />
pharmaceuticals company developing and manufacturing<br />
medicinal treatments and diagnostic tests for global<br />
markets. The company’s extensive pharmaceutical<br />
product range includes both human and veterinary<br />
pharmaceuticals as well as active pharmaceutical<br />
ingredients. Orion’s core therapeutic areas are CNS<br />
disorders, oncology, critical care, asthma and COPD.<br />
Partnerships in R&D and global marketing are<br />
elementary for Orion in the company’s growth-oriented<br />
strategy. Orion’s shares are listed on NASDAQ OMX<br />
Helsinki. For more, please visit www.orion.fi/en<br />
PAJUNK GMBH<br />
Karl-Hall-Str. 1, 78187, Geisingen, Germany<br />
T : +49 77 04 9291 549<br />
F : +49 77 04 9221 600<br />
W : www.pajunk.com<br />
E : juergen.hintz@pajunk.com<br />
Level/Booth nr. : 2M73<br />
Pajunk offers a homogenous range of products,<br />
supplying just the right medical products to fully cover<br />
the particular methods of application concerned. The<br />
Pajunk range of products are: Regional Anesthesia,<br />
Interventional Pain, Laparoscopy, Organbiopsy and<br />
Dental.<br />
Pajunk is offering needles, instruments and complete<br />
kits for Regional Anesthesia and Interventional Pain in<br />
particular for: Spinal, Epidural, CSE and Plexus.<br />
For Laparoscopy we offer besides others modular hand<br />
instruments, dilation and ring anchor ballons, trocar<br />
systems, modular suction- and irrigation system.<br />
25-27 February 2012<br />
PFIZER FRANCE<br />
23-25 avenue du Dr. Lannelongue, 75668, Paris Cedex 14,<br />
France<br />
T : +33 1 58 07 30 00<br />
F : +33 1 58 07 30 01<br />
W : www.pfizer.fr<br />
E : Virginia.hayward@pfizer.com<br />
Level/Booth nr. : 1P79<br />
At Pfizer, we apply science and our global resources to<br />
improve health and well-being at every stage of life.<br />
We strive to set the standard for quality, safety and<br />
value in the discovery, development and manufacturing<br />
of medicines for people and animals. Our diversified<br />
global health care portfolio includes human and<br />
animal biologic and small molecule medicines and<br />
vaccines, as well as nutritional products and many of<br />
the world’s best-known consumer products. Every day,<br />
Pfizer colleagues work across developed and emerging<br />
markets to advance wellness, prevention, treatments<br />
and cures that challenge the most feared diseases of our<br />
time. Consistent with our responsibility as the world’s<br />
leading biopharmaceutical company, we also collaborate<br />
with health care providers, governments and local<br />
communities to support and expand access to reliable,<br />
affordable health care around the world. For more than<br />
150 years, Pfizer has worked to make a difference for all<br />
who rely on us.<br />
PHySION<br />
Via Fogazzaro 4B, 41037, Mirandola, Italy<br />
T : +39 0535 611 082<br />
F : +39 0535 610 420<br />
W : www.physion.it<br />
E : info@physion.it<br />
Level/Booth nr. : 1P08<br />
EMDA by Physion provides accelerated localized drug<br />
administration into the bladder wall and prostatic<br />
urethra. Chemotherapy for high risk bladder tumors,<br />
Interstitial Cystitis and IPP are treated on an ambulatory<br />
basis, cost-effectively. N-DO injector catheter needle<br />
provides Localized Anesthesia for TURB and biopsies for<br />
Day Surgery management.<br />
PIERRE FABRE MéDICAMENT<br />
Parc Industrielle De La Chartreuse 2, 81106, Castres<br />
Cedex, France<br />
T : +33 563 714 500<br />
F : +33 563 714 559<br />
W : www.pierre-fabre.com<br />
E : webmaster.pfm@pierre-fabre.com<br />
Level/Booth nr. : 2M55<br />
Pierre Fabre, Gold sponsor of the <strong>EAU</strong>, is the second<br />
largest independent French pharmaceutical laboratory.<br />
The Pierre Fabre Group is present with dermo-cosmetic,<br />
OTC and medical activities.<br />
Thanks to sustained R&D investments, the group<br />
discovered new compounds to reinforce its world-wide<br />
development.<br />
Pierre Fabre Medicament is a successful partner in<br />
Urology with:<br />
- Permixon ® : an unique and recognized treatment for<br />
B.P.H., marketed in 57 countries,<br />
- Testopatch ® : recently launched in some major<br />
European countries,<br />
- Ormandyl ® for prostate cancer,<br />
- Javlor ® : in launch phase worldwide for 2nd line<br />
metastatic urothelial carcinoma.<br />
PNN MEDICAL A/S<br />
Oldenvej 13, 3490, Kvistgaard, Denmark<br />
T : +45 491 391 13<br />
F : +45 491 391 11<br />
W : www.pnnmedical.com<br />
E : ts@pnnmedical.com<br />
Level/Booth nr. : 1P41<br />
Pnn Medical specialises in minimally invasive medical<br />
devices. With the Memokath Stent Programme, we<br />
provide healthcare professionals and their patients<br />
with a safe, simple, and reliable treatment for BPH and<br />
urinary tract obstruction.<br />
Memokath is a safe, simple and reliable Nickel-<br />
Titanium stent with thermal shape-memory effect<br />
making it very gentle, safe and easy to insert. Most<br />
patients tolerate the insertion procedure well, which<br />
makes the stents an excellent option for patients who are<br />
not able or willing to go through major surgery. Patients<br />
will usually be discharged from hospital on the day of the<br />
procedure, allowing them to return to their daily routines<br />
quickly.<br />
If necessary, the Memokath stents can be removed as<br />
easily as they are inserted due to the unique design and<br />
thermal shape-memory effect.<br />
Pnn Medical has a close collaboration with medical<br />
professionals around the world which enables us to<br />
meet the demands of both healthcare professionals and<br />
patients.<br />
PROMEDON S.A.<br />
Av. Gral. Manuel Savio s/n - Lote 3 - Mza. 3., X5925 XAD,<br />
Cordoba, Argentina<br />
T : +54 351 450 21 00<br />
F : +54 351 450 21 30<br />
W : www.promedon.com<br />
E : carolinamoran@promedon.com.ar<br />
Level/Booth nr. : 2M76<br />
Promedon is a leading international company in the<br />
research, development, production and distribution<br />
of innovative medical technology for the urology and<br />
urogynecology market, present in more than 35 countries<br />
around the world.<br />
Among a wide range of solutions, Promedon offers:<br />
ARGUS, Adjustable Sling for Male Urinary Incontinence;<br />
Ophira, single incision mini sling system for female SUI;<br />
NAZCA, System for Pelvic Organ Prolapse Repair; SAFYRE<br />
VS & SAFYRE T PLUS, Adjustable Slings for Female SUI;<br />
UNITAPE VS & T Plus polypropylene suburethral slings;<br />
Vantris, an injectable bulking agent for VUR treatment<br />
and Opsys, an injectable agent for female SUI.<br />
QUANTA SySTEM SPA<br />
Via IV Novembre 116, 21058, Solbiate Olona (VA), Italy<br />
T : +39 0331 376 797<br />
F : +39 0331 367 815<br />
W : www.quantasystem.com<br />
E : quanta@quantasystem.com<br />
Level/Booth nr. : 1P52<br />
A one stop shop for laser urologic applications<br />
Quanta System lasers space from BPH to Lithotripsy<br />
fields.<br />
State of the art Thulium (CYBER TM) and cutting edge<br />
holmium lasers (LITHO) represent the real excellence in<br />
Urology,<br />
providing tangible advantages both to patients,<br />
physicians and hospitals/clinics.<br />
Powerful new virtual reality simulators for BPH<br />
(Vaporization, Vapo-Resection, Enucleation and Soft<br />
tissue treatments) train doctors to let them make<br />
experiences prior to operate live in the surgical theatre.<br />
RECORDATI<br />
Via Matteo Civitali, 1, 20148, Milan, Italy<br />
T : +39 024 878 74 68<br />
F : +39 024 878 71 26<br />
W : www.recordati.com<br />
E : praolini.m@recordati.it<br />
Level/Booth nr. : 1P96<br />
Recordati, established in 1926, is a European<br />
pharmaceutical group, listed on the Italian Stock<br />
Exchange, with a consolidated revenue of over<br />
€ 750 million. With headquarters in Milano, Italy,<br />
Recordati has operations in the main Western European<br />
Countries and a growing presence in Central and Eastern<br />
Europe, including Turkey. With a staff of almost 3,000,<br />
Recordati is dedicated to the research, development,<br />
manufacturing and marketing of pharmaceuticals. A<br />
European team of over 1,400 medical representatives<br />
inform physicians on innovative pharmaceutical products<br />
in a number of therapeutic areas, including special<br />
treatments for rare diseases. Recordati is committed<br />
to research and develop new treatments for OAB, and<br />
the co-development of NX-1207 for BPH (licensed from<br />
Nymox Pharma.). Silodosin (UROREC, SILODYX, SILOSIN),<br />
the alpha-blocker with the highest uroselectivity to date<br />
for the treatment of BPH symptoms, is now marketed by<br />
Recordati in 14 key European Countries.<br />
RICHARD WOLF GMBH<br />
Pforzheimer Str. 32, 75438, Knittlingen, Germany<br />
T : +49 704 335 0<br />
F : +49 704 335 300<br />
W : www.richard-wolf.com<br />
E : info@richard-wolf.com<br />
Level/Booth nr. : 2M50<br />
Endoscopes and lasers for stone lithotripsy<br />
R. Wolf is one of the world’s leading manufacturers<br />
of medical instruments and electronic equipment for<br />
minimal invasive surgery.<br />
The new MegaPulse 30+ Lasers form Richard Wolf are<br />
not just the smallest in their class – they also generate<br />
the biggest pulses! The MegaPulse 30+ can even carry<br />
out stone dusting with a power of max. 30 watts or 4,0<br />
joules and a frequency of max 25 hertz. They’re available<br />
in two exceptionally compact forms – as a Mini-Tower or<br />
a Desktop unit.<br />
ROCAMED & SOCOMED<br />
(PROMEPLA GROUP)<br />
9, Avenue Albert 2, Le Copori, 98000, Monaco, Monaco<br />
T : +377 979 842 32<br />
F : +377 920 561 50<br />
W : www.rocamed.eu<br />
E : info@rocamed.com<br />
Level/Booth nr. : 2M72<br />
SOCOMED & ROCAMED: capital equipment & single use<br />
disposables for Urology & Endourology.<br />
SOCOMED manufacture & distribute the ENDOFLOW<br />
System… The unique ENDOFLOW System offers heated<br />
liquid, a controlled pressure and constant liquid flow, as<br />
well as a large range of single use disposables.<br />
ROCAMED is offering a NEW & COMPLETE range of<br />
disposables & implantables within the Urology and<br />
Endourology fields.<br />
Visit our booth 2M72<br />
ROTTAPHARM | MADAUS<br />
Colonia Allee 15, 51067, Köln, Germany<br />
T : +39 039 739 04 12<br />
F : +39 039 739 03 72<br />
W : www.rotta.com<br />
E : cristina.lamberti@rottapharm.com<br />
Level/Booth nr. : 1P110<br />
The Italian multinational company Rottapharm|Madaus<br />
has established a worldwide franchise and expertise<br />
in Urology with leading products such as Spasmolyt ® /<br />
Spasmoplex ® /Uraplex ® /Ceris ® /Regurin ® (Trospium<br />
Chloride, antimuscarinic treatment for overactive<br />
bladder) and Uralyt-U ( K+ Na+ citrate for prevention<br />
of urolythiasis). New developments in the same area<br />
include the once-daily formulation of Trospium Chloride<br />
(UriVesc ® ).<br />
RUDOLF MEDICAL GMBH + CO.<br />
KG<br />
Zollerstr. 1, 78567, Fridingen, Germany<br />
T : +49 7463 99 56 0<br />
F : +49 7463 99 56 56<br />
W : www.rudolf-med.com<br />
E : mail@rudolf-med.com<br />
Level/Booth nr. : 1P07<br />
RUDOLF Medical GmbH + Co. KG translates its belief in<br />
lasting values by fostering close customer relationships<br />
and offering innovative high-technology products and<br />
efficient services.<br />
The company’s product range includes excellent<br />
INSTRUMENTS, ENDOSCOPES and EQUIPMENT LINES for<br />
numerous fields of open and minimally invasive surgery.<br />
RUDOLF offers complete product lines for urology:<br />
CYSTO-URETHROSCOPY, RESECTOSCOPY, URETHROTOMY,<br />
URETERO-RENOSCOPY, PEDIATRIC ENDO-UROLOGY and<br />
LAPAROSCOPY.<br />
RUDOLF’s integrated OR system solution is a consistent<br />
HD 1080 imaging concept which includes HDTV<br />
CAMERAS, DOCUMENTATION SYSTEMS, TELECONSULTING<br />
SYSTEM.<br />
SANOFI<br />
55 Corporate Drive, NJ 08807, Bridgewater,<br />
United States of America<br />
T : +1 908 981 46 21<br />
F : +33 158 477 860<br />
W : http://en.sanofi-aventis.com<br />
E : lisa.thornbury@sanofi.com<br />
Level/Booth nr. : 2M11<br />
Sanofi Oncology is dedicated to translating science into<br />
effective therapeutics to address unmet medical needs<br />
for cancer and organ transplant patients. We employ<br />
innovative approaches to drug discovery and clinical<br />
development, with the ultimate goal of bringing the right<br />
medicines to the right patients. Sanofi Oncology believes<br />
in the value of partnerships that combine our internal<br />
scientific expertise with that of industry and academic<br />
experts. Our portfolio includes 11 marketed products<br />
and more than 15 investigational compounds in clinical<br />
development.<br />
<strong>Exhibition</strong> <strong>Guide</strong><br />
9